ArticleStatistics in medicine2019
Meta-analysis of non-linear exposure-outcome relationships using individual participant data: A comparison of two methods.
Article in Statistics in medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Association of circulating fatty acids with cardiovascular disease risk: analysis of individual-level data in three large prospective cohorts and updated meta-analysis.European journal of preventive cardiology · 2025Pooled it
- Individual participant data meta-analysis with mixed-effects transformation models.Biostatistics (Oxford, England) · 2022Pooled it
- Pooled it
- Investigating treatment-effect modification by a continuous covariate in IPD meta-analysis: an approach using fractional polynomials.BMC medical research methodology · 2022Pooled it
- Individual participant data meta-analysis of intervention studies with time-to-event outcomes: A review of the methodology and an applied example.Research synthesis methods · 2020Pooled it
- Examining covariate-specific treatment effects in individual participant data meta-analysis: Framing aggregation bias in terms of trial-level confounding and funnel plots.Research synthesis methods · 2026Article
- Design aspects for prognostic factor studies.BMJ open · 2025Review
- Article
- Nonlinear effects and effect modification at the participant-level in IPD meta-analysis part 2: methodological guidance is available.Journal of clinical epidemiology · 2023Article
- Nonlinear effects and effect modification at the participant-level in IPD meta-analysis part 1: analysis methods are often substandard.Journal of clinical epidemiology · 2023Article
- Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses.Circulation · 2022Observational
- Article
- Predicting personalised absolute treatment effects in individual participant data meta-analysis: An introduction to splines.Research synthesis methods · 2022Article
- Meta-analysis for individual participant data with a continuous exposure: A case study.Journal of clinical epidemiology · 2021Article
- Combining Longitudinal Data From Different Cohorts to Examine the Life-Course Trajectory.American journal of epidemiology · 2021Article
- Polygenic basis and biomedical consequences of telomere length variation.Nature genetics · 2021Article
- Linear and Nonlinear Mendelian Randomization Analyses of the Association Between Diastolic Blood Pressure and Cardiovascular Events: The J-Curve Revisited.Circulation · 2021Article
- Individual participant data meta-analysis to examine interactions between treatment effect and participant-level covariates: Statistical recommendations for conduct and planning.Statistics in medicine · 2020Article
- Meta-analysis of non-linear exposure-outcome relationships using individual participant data: A comparison of two methods.Statistics in medicine · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Non-linear exposure-outcome relationships such as between body mass index (BMI) and mortality are common. They are best explored as continuous functions using individual participant data from multiple studies. We explore two two-stage methods for meta-analysis of such relationships, where the confounder-adjusted relationship is first estimated in a non-linear regression model in each study, then combined across studies. The "metacurve" approach combines the estimated curves using multiple meta-analyses of the relative effect between a given exposure level and a reference level. The "mvmeta" approach combines the estimated model parameters in a single multivariate meta-analysis. Both methods allow the exposure-outcome relationship to differ across studies. Using theoretical arguments, we show that the methods differ most when covariate distributions differ across studies; using simulated data, we show that mvmeta gains precision but metacurve is more robust to model mis-specification. We then compare the two methods using data from the Emerging Risk Factors Collaboration on BMI, coronary heart disease events, and all-cause mortality (>80 cohorts, >18 000 events). For each outcome, we model BMI using fractional polynomials of degree 2 in each study, with adjustment for confounders. For metacurve, the powers defining the fractional polynomials may be study-specific or common across studies. For coronary heart disease, metacurve with common powers and mvmeta correctly identify a small increase in risk in the lowest levels of BMI, but metacurve with study-specific powers does not. For all-cause mortality, all methods identify a steep U-shape. The metacurve and mvmeta methods perform well in combining complex exposure-disease relationships across studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.